Update on Biomarkers in Allergy and Asthma, An Issue of Immunology and Allergy Clinics, 1st Edition
Author :
Rohit K. Katial
This issue of Immunology and Allergy Clinics provides a comprehensive review of the current state of biomarkers and their role in the asthma diagnostic and therapeutic algorithm.Since the last issue on Biomarkers, which published in 2007, significant
...view more
This issue of Immunology and Allergy Clinics provides a comprehensive review of the current state of biomarkers and their role in the asthma diagnostic and therapeutic algorithm.Since the last issue on Biomarkers, which published in 2007, significant research directly targeted at biomarker development and clinical trials with new biologics, using biomarkers such as exhaled nitric oxide, sputum and tissue eosinophilia as endpoints, has occurred.
This issue of Immunology and Allergy Clinics provides a comprehensive review of the current state of biomarkers and their role in the asthma diagnostic and therapeutic algorithm.Since the last issue on Biomarkers, which published in 2007, significant research directly targeted at biomarker development and clinical trials with new biologics, using biomarkers such as exhaled nitric oxide, sputum and tissue eosinophilia as endpoints, has occurred.
Author Information
By Rohit K. Katial, MD, Allergist and Immunologist, National Jewish Health, Division of Allergy and Clinical Immunology, Denver Colorado
https://www.us.elsevierhealth.com/update-on-biomarkers-in-allergy-and-asthma-an-issue-of-immunology-and-allergy-clinics-9781455750917.html7016Update on Biomarkers in Allergy and Asthma, An Issue of Immunology and Allergy Clinicshttps://www.us.elsevierhealth.com/media/catalog/product/9/7/9781455750917.jpg79.1998.99USDInStock/Medicine/Allergy/Clinics/Clinics15943887255255041This issue of Immunology and Allergy Clinics provides a comprehensive review of the current state of biomarkers and their role in the asthma diagnostic and therapeutic algorithm.Since the last issue on Biomarkers, which published in 2007, significant research directly targeted at biomarker development and clinical trials with new biologics, using biomarkers such as exhaled nitric oxide, sputum and tissue eosinophilia as endpoints, has occurred. This issue of Immunology and Allergy Clinics provides a comprehensive review of the current state of biomarkers and their role in the asthma diagnostic and therapeutic algorithm.Since the last issue on Biomarkers, which published in 2007, significant research directly targeted at biomarker development and clinical trials with new biologics, using biomarkers such as exhaled nitric oxide, sputum and tissue eosinophilia as endpoints, has occurred.00add-to-cart97814557509172012ProfessionalBy Rohit K. Katial, MD20121Book152w x 229hSaunders0Aug 19, 2012IN STOCK - This may take up to 5 business days to shipBy <STRONG>Rohit K. Katial</STRONG>, MD, Allergist and Immunologist, National Jewish Health, Division of Allergy and Clinical Immunology, Denver ColoradoClinicsClinicsThe Clinics: Internal MedicineNoNoNoNoPlease SelectPlease SelectPlease Select
